Copyright Reports & Markets. All rights reserved.

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Vascular Endothelial Growth Factor (VEGF) Inhibitors
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Vascular Endothelial Growth Factor (VEGF) Inhibitors by Type
    • 1.3.1 Overview: Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value Market Share by Type in 2023
    • 1.3.3 VEGF-A Inhibitor
    • 1.3.4 VEGF-B Inhibitor
    • 1.3.5 VEGF-C Inhibitor
    • 1.3.6 VEGF-D Inhibitor
  • 1.4 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market by Application
    • 1.4.1 Overview: Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Oncology
    • 1.4.3 Ophthalmology
  • 1.5 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size & Forecast
  • 1.6 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast by Region
    • 1.6.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region, (2019-2030)
    • 1.6.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Prospect (2019-2030)
    • 1.6.6 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Bayer AG
    • 2.1.1 Bayer AG Details
    • 2.1.2 Bayer AG Major Business
    • 2.1.3 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Solutions
    • 2.1.4 Bayer AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bayer AG Recent Developments and Future Plans
  • 2.2 F. Hoffmann-La Roche Ltd.
    • 2.2.1 F. Hoffmann-La Roche Ltd. Details
    • 2.2.2 F. Hoffmann-La Roche Ltd. Major Business
    • 2.2.3 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Solutions
    • 2.2.4 F. Hoffmann-La Roche Ltd. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
  • 2.3 Novartis AG
    • 2.3.1 Novartis AG Details
    • 2.3.2 Novartis AG Major Business
    • 2.3.3 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Solutions
    • 2.3.4 Novartis AG Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Novartis AG Recent Developments and Future Plans
  • 2.4 Regeneron Pharmaceuticals Inc.
    • 2.4.1 Regeneron Pharmaceuticals Inc. Details
    • 2.4.2 Regeneron Pharmaceuticals Inc. Major Business
    • 2.4.3 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Solutions
    • 2.4.4 Regeneron Pharmaceuticals Inc. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Regeneron Pharmaceuticals Inc. Recent Developments and Future Plans
  • 2.5 Sanofi.
    • 2.5.1 Sanofi. Details
    • 2.5.2 Sanofi. Major Business
    • 2.5.3 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product and Solutions
    • 2.5.4 Sanofi. Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Sanofi. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Vascular Endothelial Growth Factor (VEGF) Inhibitors by Company Revenue
    • 3.2.2 Top 3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Players Market Share in 2023
    • 3.2.3 Top 6 Vascular Endothelial Growth Factor (VEGF) Inhibitors Players Market Share in 2023
  • 3.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Overall Company Footprint Analysis
    • 3.3.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Region Footprint
    • 3.3.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Company Product Type Footprint
    • 3.3.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Type (2019-2030)
  • 6.2 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Application (2019-2030)
  • 6.3 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
    • 6.3.1 North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Country (2019-2030)
    • 6.3.2 United States Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Type (2019-2030)
  • 7.2 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Application (2019-2030)
  • 7.3 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
    • 7.3.1 Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 7.3.3 France Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Region
    • 8.3.1 Asia-Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Region (2019-2030)
    • 8.3.2 China Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 8.3.5 India Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Type (2019-2030)
  • 9.2 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Application (2019-2030)
  • 9.3 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
    • 9.3.1 South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size by Country
    • 10.3.1 Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Drivers
  • 11.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Restraints
  • 11.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Vascular Endothelial Growth Factor (VEGF) Inhibitors Industry Chain
  • 12.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors Upstream Analysis
  • 12.3 Vascular Endothelial Growth Factor (VEGF) Inhibitors Midstream Analysis
  • 12.4 Vascular Endothelial Growth Factor (VEGF) Inhibitors Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Vascular endothelial growth factor inhibitors, also known as angiogenesis inhibitors, can prevent the generation of new blood vessels.
    According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
    The Global Info Research report includes an overview of the development of the Vascular Endothelial Growth Factor (VEGF) Inhibitors industry chain, the market status of Oncology (VEGF-A Inhibitor, VEGF-B Inhibitor), Ophthalmology (VEGF-A Inhibitor, VEGF-B Inhibitor), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Vascular Endothelial Growth Factor (VEGF) Inhibitors.
    Regionally, the report analyzes the Vascular Endothelial Growth Factor (VEGF) Inhibitors markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Vascular Endothelial Growth Factor (VEGF) Inhibitors market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Vascular Endothelial Growth Factor (VEGF) Inhibitors market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Vascular Endothelial Growth Factor (VEGF) Inhibitors industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., VEGF-A Inhibitor, VEGF-B Inhibitor).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Vascular Endothelial Growth Factor (VEGF) Inhibitors market.
    Regional Analysis: The report involves examining the Vascular Endothelial Growth Factor (VEGF) Inhibitors market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Vascular Endothelial Growth Factor (VEGF) Inhibitors market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Vascular Endothelial Growth Factor (VEGF) Inhibitors:
    Company Analysis: Report covers individual Vascular Endothelial Growth Factor (VEGF) Inhibitors players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Vascular Endothelial Growth Factor (VEGF) Inhibitors This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Ophthalmology).
    Technology Analysis: Report covers specific technologies relevant to Vascular Endothelial Growth Factor (VEGF) Inhibitors. It assesses the current state, advancements, and potential future developments in Vascular Endothelial Growth Factor (VEGF) Inhibitors areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Vascular Endothelial Growth Factor (VEGF) Inhibitors market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Vascular Endothelial Growth Factor (VEGF) Inhibitors market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    VEGF-A Inhibitor
    VEGF-B Inhibitor
    VEGF-C Inhibitor
    VEGF-D Inhibitor
    Market segment by Application
    Oncology
    Ophthalmology
    Market segment by players, this report covers
    Bayer AG
    F. Hoffmann-La Roche Ltd.
    Novartis AG
    Regeneron Pharmaceuticals Inc.
    Sanofi.
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Vascular Endothelial Growth Factor (VEGF) Inhibitors product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Vascular Endothelial Growth Factor (VEGF) Inhibitors, with revenue, gross margin and global market share of Vascular Endothelial Growth Factor (VEGF) Inhibitors from 2019 to 2024.
    Chapter 3, the Vascular Endothelial Growth Factor (VEGF) Inhibitors competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Vascular Endothelial Growth Factor (VEGF) Inhibitors market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Vascular Endothelial Growth Factor (VEGF) Inhibitors.
    Chapter 13, to describe Vascular Endothelial Growth Factor (VEGF) Inhibitors research findings and conclusion.

    Buy now